Sort
23,748 grants matching “melanoma”
MELANOMA ASSOCIATED T AND DC DYSFUNCTION AND DEATH
$301,050University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA
Core 3: Rexinoid Screening and Animal Core
$300,986Mohammad Athar · University Of Alabama At Birmingham · P01 · FY2018 · CA
Core 3: Rexinoid Screening and Animal Core
$300,986Mohammad Athar · University Of Alabama At Birmingham · P01 · FY2017 · CA
Costimulatory mechanisms of antitumor Th17 cell immunity
$300,907Chrystal Mary Paulos · Medical University Of South Carolina · R01 · FY2014 · CA
Large Stress Proteins in Biology and Medicine
$300,907Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2014 · CA
B7-H1 Signaling in Ovarian Cancer
$300,907Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2014 · CA
Pancreatic Cancer Management by Novel Gene Therapy & Dietary Agents
$300,907Paul B Fisher · Virginia Commonwealth University · R01 · FY2011 · CA
Analysis of a novel regulator of hepatocellular carcinoma
$300,907Devanand Sarkar · Virginia Commonwealth University · R01 · FY2011 · CA
Analysis of a novel regulator of hepatocellular carcinoma
$300,907Devanand Sarkar · Virginia Commonwealth University · R01 · FY2012 · CA
Pancreatic Cancer Management by Novel Gene Therapy & Dietary Agents
$300,907Paul B Fisher · Virginia Commonwealth University · R01 · FY2012 · CA
Multiscale microscope for 3D cancer imaging in model organisms and organoids
$300,887Reto Paul Fiolka · Ut Southwestern Medical Center · R33 · FY2021 · CA
Multiscale microscope for 3D cancer imaging in model organisms and organoids
$300,887Reto Paul Fiolka · Ut Southwestern Medical Center · R33 · FY2020 · CA
Mechanism and role of DLC-1 tumor suppressor loss in lung cancer
$300,879Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2008 · CA
rAAV vaccine vector
$300,875Selvarangan Ponnazhagan · University Of Alabama At Birmingham · R01 · FY2010 · CA
rAAV vaccine vector
$300,875Selvarangan Ponnazhagan · University Of Alabama At Birmingham · R01 · FY2009 · CA
Novel selective small-molecule inhibitors of Mcl-1 protein
$300,858Zaneta Nikolovska-Coleska · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
IL-2 Neuropsychiatric Symptoms: Mechanisms, Prevention
$300,841Dominique L. Musselman · Emory University · R01 · FY2008 · MH
IL-2 Neuropsychiatric Symptoms: Mechanisms, Prevention
$300,841Dominique L. Musselman · Emory University · R01 · FY2007 · MH
ANTIBODY-TARGETED POLYMERIC SYSTEMS FOR TUMOR IMAGING
$300,789Northeastern University · R01 · FY2004 · EB
Targeting the developmental pathways Notch and ERBB for melanoma therapy
$300,764Barbara Bedogni · University Of Miami School Of Medicine · R01 · FY2018 · CA
Characterization of Tumor Specific T Cells in Melanoma
$300,732Stanford University · R01 · FY2003 · CA
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes
$300,709Marianne Berwick · University Of New Mexico Health Scis Ctr · P01 · FY2018 · CA
Epigenetic and post-translational regulation of the metastasis suppressor BRMS1
$300,684David R Jones · University Of Virginia · R01 · FY2009 · CA
SunSmart America: Evaluating a School-based Curriculum
$300,672Robert Scott Kirsner · University Of Miami School Of Medicine · R25 · FY2008 · CA
Templated Chemistry for RNA Analysis
$300,631Eric T. Kool · Stanford University · R01 · FY2014 · GM